Clinical Trial Update: Visanne Study to Assess Safety in Adolescents [Phase 2]

View source ↗

Summary

Visanne (dienogest) Phase 2 safety study in adolescents with endometriosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometriosis

Drugs mentioned

• Visanne (Dienogest)

Snippet

Sponsor: Bayer | Conditions: Endometriosis | Phase 2 | Status: COMPLETED